Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Androgens Stories

2014-04-19 23:00:30

The Firm is currently offering free and confidential testosterone lawsuit evaluations to men who allegedly suffered heart attacks, strokes, deep vein thrombosis or pulmonary embolism, after taking AndroGel, Testim, Axiron or another prescription testosterone therapy. New York, NY (PRWEB) April 19, 2014 As AndroGel and other hormone-raising therapies continue to be named in testosterone lawsuit (http://www.testosteronelawsuitclaims.com/) allegations, Bernstein Liebhard LLP has launched a...

2014-04-18 23:07:51

The debate over the extent to which testosterone supplements may contribute to heart attack has medical experts weighing in with contradictory opinions on the issue. To understand the opposing views, and the background for recent testosterone lawsuits, LawyersandSettlments.com spoke with two of the leading voices in the debate—Dr. Abraham Morgantaler, Director of Men’s Health Boston, and Dr. Michael Carome, Public Citizen’s Director of the Health Research Group Boston, MA (PRWEB)...

2014-04-15 23:09:37

Plaintiffs Seek Transfer of all Federal AndroGel Lawsuits to U.S. District Court, Northern District of Illinois, For Coordinated Pretrial Proceedings New York, NY (PRWEB) April 15, 2014 Alonso Krangle LLP, an experienced defective drug injury law firm, reports that plaintiffs who have filed AndroGel testosterone lawsuits alleging the low testosterone therapy caused men to suffer heart attacks, strokes and other serious heart problems are seeking the transfer of all federally-filed cases...

2014-04-15 23:02:22

The Firm is evaluating testosterone treatment lawsuits on behalf of men who suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, and other cardiovascular problems allegedly due to the use of prescription low testosterone therapies. New York, New York (PRWEB) April 15, 2014 As testosterone lawsuits (http://www.testosteronelawsuitcenter.com/) involving AndroGel and other low testosterone therapies continue to move forward in U.S. courts, Bernstein Liebhard LLP notes...

2014-04-15 23:01:01

The European Medicines Agency (EMA) is investigating the potential cardiovascular risks of testosterone therapies, according to a report in MedPage Today. In January, the U.S. Food and Drug Administration (FDA) also began investigating these products; both agencies launched their reviews due to two studies linking testosterone drugs to a higher risk of heart attack and other cardiovascular issues. New York, New York (PRWEB) April 15, 2014 Parker Waichman LLP, a national law firm dedicated...

2014-04-14 23:12:02

National network of attorneys now offering no-cost consultations in connection with FDA's announcement that safety of testosterone treatments is under review. San Diego, CA (PRWEB) April 14, 2014 http://www.resource4thepeople.com/defectivedrugs/testosteronetreatments-lawsuits.html Resource4thePeople announced today its latest update for consumers who may be considering legal action over concerns about heart attacks and strokes from testosterone treatments as detailed in a recent Food...

2014-04-14 23:02:28

Plaintiff Alleges His Three Heart Attacks Were the Result of AndroGel, a Low Testosterone Therapy Gel He Used for Over Two Years New York, NY (PRWEB) April 14, 2014 A new AndroGel lawsuit has been filed in Illinois federal court on behalf of a Georgia man who is seeking actual and compensatory damages for heart attacks he contends were caused by the low testosterone therapy. The complaint, which was filed in the U.S. District Court, Northern District of Illinois, on March 12, 2014,...

2014-04-14 23:01:22

The Firm is evaluating Testosterone lawsuits on behalf of individuals who experienced life-threatening heart problems, allegedly due to Testim and other low-testosterone therapies. New York, New York (PRWEB) April 14, 2014 Testosterone treatment lawsuits (http://www.testosteronelawsuitcenter.com/) are now being filed in courts around the country on behalf of men who allegedly suffered life-threatening heart problems due to prescription medications used to treat hypgonadism (low...

2014-04-14 20:21:01

DUBLIN, April 14, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/fvzl65/global) has announced the addition of the "Global Testosterone Market Report" [http://www.researchandmarkets.com/research/fvzl65/global ] report to their offering. The analysts forecast the Global Testosterone market to grow at a CAGR of 26.26 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging...

2014-04-10 23:29:52

More Than 30 AndroGel Lawsuits Have Been Filed in Federal Courts Since FDA Announced Safety Review of Heart Risks Potentially Associated with Low Testosterone Therapy Medications. Columbus, OH (PRWEB) April 10, 2014 With more than 30 AndroGel lawsuits now pending in federal courts around the country, plaintiffs are seeking to have the cases consolidated in a multidistrict litigation and transferred to U.S. District Court, Northern District of Illinois for coordinated pretrial proceedings....